Sanara MedTech Inc. Board of Directors

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Mr. Ronald T. Nixon

Mr. Ronald T. Nixon

Executive Chairman & CEO

Ms. Tricia Matteson

Ms. Tricia Matteson

Vice President of Marketing

Ms. Elizabeth B. Taylor

Ms. Elizabeth B. Taylor

Chief Financial Officer

Mr. Michael D. McNeil

Mr. Michael D. McNeil

Chief Accounting & Administrative Officer and Corporate Secretary

Mr. Seth Yon

Mr. Seth Yon

President of Commercial

Dr. Rebecca Erin Mcmahon

Dr. Rebecca Erin Mcmahon

President of Research & Development

Mr. Tyler Palmer

Mr. Tyler Palmer

Chief Corporate Development & Strategy Officer

Mr. Jacob A. Waldrop

Mr. Jacob A. Waldrop

Chief Operating Officer

Mr. Bill Fitzgerald

Mr. Bill Fitzgerald

Chief Compliance Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.